Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Dewasurendra, Rajika Lasanthi ^a   Dias, Janaka Nandana ^b   Sepulveda, Nuno ^c,d   Gunawardena, Geethika Sharmini Abayaweera ^a   Chandrasekharan, Naduviladath ^e   Drakeley, Chris ^c   Karunaweera, Nadira Dharshani ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b MOH HOLDINGS PTE LTD   (Singapore)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Center of Statistics Applications of Lisbon University CEAUL   (Portugal)

^e UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Anti malarial antibodies; ELISA; Reversible catalytic model; Sero positivity; Sri Lanka

Indexed keywords

APICAL MEMBRANE PROTEIN 1 ANTIBODY; MEROZOITE SURFACE PROTEIN 1 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; PROTOZOON ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; OPTICAL DENSITY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; SEROCONVERSION; SERODIAGNOSIS; SEROPREVALENCE; SRI LANKA; AGED; BLOOD; CASE CONTROL STUDY; COST BENEFIT ANALYSIS; IMMUNOLOGY; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; MIDDLE AGED; PATHOGENICITY; PRESCHOOL CHILD; SEROEPIDEMIOLOGY; SOCIOECONOMICS; TRANSMISSION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; SRI LANKA; YOUNG ADULT;

EID: 85011339295     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-2164-0     Document Type: Article

References (33)

1. World Health Organization. World Malaria Report. Geneva, Switzerland. 2013. http://www.who.int/malaria/publications/world_malaria_report_2013/wmr2013_country_profiles.pdf?ua=1. Accessed Dec 2015.
2. Karunaweera ND, Galappaththy GN, Wirth DF. On the road to eliminate malaria in Sri Lanka: lessons from history, challenges, gaps in knowledge and research needs. Malar J. 2014;13(1):59.
3. Hay SI, Smith DL, Snow RW. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis. 2008;8(6):369-78.
4. Cook J, Reid H, Ivaro J, Kuwahata M, Taleo G, Clements A, et al. Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J. 2010;9:169.
5. Corran PH, Coleman P, Riley EM, Drakeley C. Serology: a robust indicator of malaria transmission intensity? Trends Parasitol. 2007;23(12):575-82.
6. Abeysinghe RR, Galappaththy GNL, Gueye CS, Kahn JG, Feachem RGA, Abeyasinghe RR, et al. Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One. 2012;7(8):e43162.
7. World Health Organization. WHO certifies Sri Lanka malaria-free [Internet]. 2016. www.searo.who.int/mediacentre/releases/2016/1631/en. Accessed 30 Sept 2016.
8. Rajakaruna RS, Alifrangis M, Amerasinghe PH, Konradsen F. Pre-elimination stage of malaria in Sri Lanka: assessing the level of hidden parasites in the population. Malar J. 2010;9:25.
9. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, et al. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLOS One. 2009;4:6.
10. Drakeley C, Corran PH, Coleman P, Tongren JE, McDonald SLR, Carneiro I, et al. Estimating medium and long term trends in malaria transmission by using serological markers of malaria exposure. PNAS. 2005;102:14. www.pnas.org/cgi/doi/10.1073/pnas.0408725102.
11. Cunha MG, Silva ES, Sepulveda N, Costa APT, Saboia TC, Guerreiro JF, et al. Serologically defined variations in malaria endemicity in Para State, Brazil. PLoS One. 2014;9:11.
12. Bruce-Chwatt LJ, Draper CC, Konfortion P. Seroepidemiological evidence of eradication of malaria from mauritius. Lancet. 1973;2(7828):547-51.
13. Bruce-Chwatt LJ, Draper CC, Avramidis D, Kazandzoglou O. Sero-epidemiological surveillance of disappearing malaria in Greece. J Trop Med Hyg. 1975;78(9):194-200.
14. Voller A, Bruce-Chwatt LJ. Serological malaria surveys in Nigeria. Bull Wld Hlth Org. 1968;39:883-97.
15. Dewasurendra RL, Suriyaphol P, Fernando SD, Carter R, Rockett K, Corran PH, et al. Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka. Malar J. 2012;11:281.
16. Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, Mosha F, et al. Identification of Hot spots of malaria transmission for targeted malaria control. J Infect Dis. 2010;201(11):1764-74. http://jid.oxfordjournals.org/lookup/doi/10.1086/652456.
17. Cook J, Reid H, Ivaro J, Kuwahata M, Taleo G, Clements A, et al. Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J. 2010;9:169. http://www.malariajournal.com/cntent/9/1/169.
18. Anti malaria campaign, Ministry of Health, Sri Lanka. http://www.malariacampaign.gov.lk/Precentation/AnnualReports.aspx. Accessed Dec 2015.
19. Badu K, Afrane YA, Labri J, Stewart VA, Waitumbi J, Angov E, et al. Marked variation in MSP-119 antibody responses to malaria in western Kenyan highlands. BMC Infect Dis. 2012;12:50.
20. Department of Census and Statistics Sri Lanka. http://www.statistics.gov.lk/. Accessed Dec 2014.
21. Sepulveda N, Drakeley C. Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity. Malar J. 2015;14:141.
22. Sepulveda N, Paulino CD, Drakeley C. Sample size and power calculation for detecting changes in malaria transmission using antibody serocnversion rate. Malar J. 2015;14:529.
23. Sepulveda N, Stresman G, White MT, Drakeley CJ. Current mathematical models for analyzing anti-malarial antibody data with an eye to malaria elimination and eradication. J Immunol Res. 2015. doi: 10.1155/2015/738030.
24. Dudovskiy J. Res Methodol. 2011. http://www.research-methodology.net/sampling-in-primary-data-collection/quota-sampling/. Accessed 2 Nov 2016.
25. Wipasa J, Suphavilai C, Okell LC, Cook J, Corran PH, Thaikla K, et al. Long-lived antibody and B cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax. Plos Pathog. 2010;6:2.
26. Druilhe P, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G. Levels of antibodies to plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immun. 1986;53(2):393-7.
27. Ondigo BN, Hodges JS, Ireland KF, Magak NG, Lanar DE, Datta S, et al. Estimation of Recent and Long term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens. J Infect Dis. 2014;8.
28. Donahue C, Carruthers V, Gilk S, Ward G. The Toxoplasma homolog of plasmodium apical membrane antigen 1 (AMA1) is a microneme protein secreted in response to elevated intracellular calcium levels. Mol Biochem Parasitol. 2000;111:15-30.
29. Gaffar F, Yatsuda A, Frits F, Franssen J, de Vries E. Erythrocyte invasion by Babesia bovis merozoites in inhibited by polyclonal antisera directed against peptides derived from a homologue of Plasmodium falciparum apical membrane antigen 1. Infect Immune. 2004;72(5):2947-55.
30. Ferreira MU, Liu Q, Kimura M, Nadawi BT, Tanabe K, Kawamoto F. Allelic diversity in the merozoite surface protein-1 and epidemiology of multiple-clone Plasmodium falciparum infections in Northern Tanzania. J Parasitol. 1998;84(6):1286-9. http://www.jstor.org/stable/3284693.
31. Bai T, Becker M, Gupta A, Strike P, Murphy VJ, Anders RF, et al. Structure of AMA1 from plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. PNAS. 2005;102(36):12736-41.
32. Amanfo SA, Mduluza T, Midzi N, Cavanagh DR, Mutapi F. Seroepidemiology of Plasmodium species infections in Zimbabwean population. Malar J BioMed Central. 2016;15:1-10. http://dx.doi.org/10.1186/s12936-016-1325-3.
33. Igonet S, Normand BV, Faure G, Riottot M, Cocken CHM, Thomas AW, et al. Cross-reactivity studies of an anti-Plasmodium vivax Apical Membrane Antigen 1 Monoclonal Antibody: Binding and structural characterisation. J Mol Biol. 2007;366(5):1523-37.